Even though these studies support the association of brain-age delta as a biomarker of biological aging with relevance to various brain diseases, it is of interest to further validate this measurement in association with specific biological markers of AD pathology (i.e. Amyloid-β[Aβ] and tau pathology), neurodegeneration and cerebrovascular disease in the earliest stages of AD. Here, MAPT is linked to Alzheimer disease.